These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20933473)

  • 1. Knowledge, attitudes and current practice of Jordanian family physicians about prescribing aspirin in primary and secondary prevention of vascular diseases: a self-reported survey.
    Al Omari M; Khader Y; Al-azzam SI; Dauod AS; Khassawneh AH; Alomari N; Alzoubi KH
    Eur J Cardiovasc Nurs; 2012 Mar; 11(1):9-13. PubMed ID: 20933473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential use of 10-year and lifetime coronary risk information for preventive cardiology prescribing decisions: a primary care physician survey.
    Persell SD; Zei C; Cameron KA; Zielinski M; Lloyd-Jones DM
    Arch Intern Med; 2010 Mar; 170(5):470-7. PubMed ID: 20212185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.
    Jones L; Griffin S; Palmer S; Main C; Orton V; Sculpher M; Sudlow C; Henderson R; Hawkins N; Riemsma R
    Health Technol Assess; 2004 Oct; 8(38):iii-iv, 1-196. PubMed ID: 15461876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to guidelines for the prescribing of double and triple combinations of antithrombotic agents.
    Warlé-Van Herwaarden MF; Roukens M; Pop GA; Lamfers EJ; De Smet PA; Kramers C
    Eur J Prev Cardiol; 2014 Feb; 21(2):231-43. PubMed ID: 22684153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of early aspirin in suspected acute myocardial infarction by General Practitioners in Sri Lanka.
    Seneviratne SL; Gunatilake SB; de Silva HJ
    Int J Cardiol; 1997 Jan; 58(2):171-3. PubMed ID: 9049682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physicians.
    Viera AJ; Sheridan SL; Edwards T; Soliman EZ; Harris R; Furberg CD
    Prev Med; 2011 Jan; 52(1):10-5. PubMed ID: 20933538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.
    Antithrombotic Trialists' Collaboration
    BMJ; 2002 Jan; 324(7329):71-86. PubMed ID: 11786451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Large-Scale Linkage Data to Evaluate the Effectiveness of a National Educational Program on Antithrombotic Prescribing and Associated Stroke Prevention in Primary Care.
    Liu Z; Moorin R; Worthington J; Tofler G; Bartlett M; Khan R; Zuo Y
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27737875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of pharmaceutical promotion on prescribers in Jordan.
    Altawalbeh SM; Ibrahim IA; Al-Shatnawi SF
    Int J Clin Pharm; 2020 Apr; 42(2):744-755. PubMed ID: 32140917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative knowledge and practice of emergency physicians, cardiologists, and primary care practitioners regarding drug therapy for acute myocardial infarction.
    Melniker LA; Leo PJ
    Chest; 1998 Feb; 113(2):297-305. PubMed ID: 9498942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why are eligible patients not prescribed aspirin in primary care? A qualitative study indicating measures for improvement.
    Short D; Frischer M; Bashford J; Ashcroft D
    BMC Fam Pract; 2003 Jul; 4():9. PubMed ID: 12871601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease.
    Aronow WS
    Drugs Aging; 1999 Aug; 15(2):91-101. PubMed ID: 10495069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of changing guidelines on prescribing aspirin for primary prevention of cardiovascular events.
    Hissett J; Folks B; Coombs L; Leblanc W; Pace WD
    J Am Board Fam Med; 2014; 27(1):78-86. PubMed ID: 24390889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction.
    Kizer JR; Cannon CP; McCabe CH; Mueller HS; Schweiger MJ; Davis VG; Perritt R; Antman EM
    Am Heart J; 1999 Jan; 137(1):79-92. PubMed ID: 9878939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of aspirin for primary and secondary cardiovascular disease prevention in the United States, 2011-2012.
    Mainous AG; Tanner RJ; Shorr RI; Limacher MC
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25023071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke. Medical therapy in patients with carotid artery stenosis.
    Goldstein LB; Bonito AJ; Matchar DB; Duncan PW; Samsa GP
    Stroke; 1996 Sep; 27(9):1473-8. PubMed ID: 8784115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of vascular events in patients with atrial fibrillation: evidence, guidelines, and practice.
    Connolly SJ
    J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S52-5. PubMed ID: 12950519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based medicine among Jordanian family physicians: awareness, attitude, and knowledge.
    Barghouti F; Halaseh L; Said T; Mousa AH; Dabdoub A
    Can Fam Physician; 2009 Jul; 55(7):e6-13. PubMed ID: 19602641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study.
    Li L; Geraghty OC; Mehta Z; Rothwell PM;
    Lancet; 2017 Jul; 390(10093):490-499. PubMed ID: 28622955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.